When it comes to addressing the national opioid crisis, most of the research has focused on the physical health risks faced by people with opioid use disorder, such as overdose and infectious disease. For the first time, a University of Massachusetts Amherst public health scientist studied the impact of treating opioid use disorder on the […]Continue Reading ...
Credit: CC0 Public Domain Geneticists discovered a molecular trigger for a severe autism-related disorder that has enabled them to start testing a potential therapy targeting a specific protein in the brain. A UT Southwestern study involving humans and mice details one of the few instances in which researchers have found a precise pathway that causes […]Continue Reading ...
An investigation led by a team of researchers from the Massachusetts General Hospital (MGH) departments of Neurology, Psychiatry and Radiology has found altered connectivity among brain regions that handle sensorimotor, emotional and cognitive signaling in patients with functional neurological disorder, a common condition involving neurologic symptoms that have no readily apparent physical cause. Their report […]Continue Reading ...
New research published in Depression and Anxiety indicates that, unlike other anxiety disorders, social anxiety disorder may have a direct effect on alcoholism. For the study, researchers assessed alcoholism, social anxiety disorder, generalized anxiety disorder, panic disorder, agoraphobia, and specific phobias through interviews with 2,801 adult Norwegian twins. Social anxiety disorder had the strongest association […]Continue Reading ...
A large multi-center study of more than 1,200 patients provides important predictors of Parkinson’s disease progression, which will allow better candidate selection for clinical trials and more effective therapy development. The study, led by Dr. Ron Postuma at The Neuro (Montreal Neurological Institute and Hospital) and the Montreal General Hospital of the McGill University Health […]Continue Reading ...
MONDAY, Feb. 11, 2019 — If you’re worried that your child may suffer from a mental health condition, such as anxiety, depression or attention-deficit/hyperactivity disorder (ADHD), you have plenty of company. About one in every six American kids has at least one mental health disorder, new research shows. But the study delivered even more troubling […]Continue Reading ...
Children’s risk of being diagnosed with reactive attachment disorder (RAD) increases if parents are diagnosed with any type of mental health disorder, discovered researchers from the Research Centre for Child Psychiatry of the University of Turku, Finland. Particularly parents’ alcohol and drug addiction and mother’s depression were associated with reactive attachment disorder in children. The […]Continue Reading ...
lemborexant Treatment for Insomnia New Drug Application for Insomnia Disorder Treatment Lemborexant Submitted in the United States TOKYO and STAMFORD, Conn. – January 15, 2019 – Eisai Co., Ltd. (CEO: Haruo Naito, “Eisai”) and Purdue Pharma L.P. (President and CEO: Craig Landau, MD, “Purdue Pharma”) today announced that a new drug application has been submitted […]Continue Reading ...
NEW HAVEN, Conn., Feb. 20, 2019 /PRNewswire/ — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neuropsychiatric diseases, today announced that it has enrolled its first patient in a Phase 3 clinical trial assessing the efficacy and safety of troriluzole in generalized anxiety […]Continue Reading ...
Research in the past several years has shown that children can outgrow a diagnosis of autism spectrum disorder (ASD), once considered a lifelong condition. In a new study, researchers at Albert Einstein College of Medicine and Montefiore Health System have found that the vast majority of such children still have difficulties that require therapeutic and […]Continue Reading ...
Credit: CC0 Public Domain A large multi-centre study of more than 1,200 patients provides important predictors of Parkinson’s disease progression, which will allow better candidate selection for clinical trials and more effective therapy development. The study, led by Dr. Ron Postuma at The Neuro (Montreal Neurological Institute and Hospital) and the Montreal General Hospital of […]Continue Reading ...
Some variations in the gene LPHN3 -associated with the attention deficit/hyperactivity disorder (ADHD) in kids and adults- could favor likelihood to smoke, consume alcohol, cannabis and other addictive substances, according to an article published in the journal Translational Psychiatry, from the Nature Publishing Group. The findings are based on the study of around 2,700 patients […]Continue Reading ...
A genome-wide association study in Biological Psychiatry examines the role of copy number variants in subtypes of bipolar disorder A form of rare genomic structural variation called copy number variants (CNVs) may be more closely associated with schizophrenia than bipolar disorder. A new study published in Biological Psychiatry failed to find that CNVs were associated […]Continue Reading ...
TUESDAY, Jan. 15, 2019 — Patients with Tourette syndrome (TS) or chronic tic disorder (CTD) have an increased risk for developing at least one metabolic or cardiovascular disorder, according to a study published online Jan. 14 in JAMA Neurology. Gustaf Brander, from the Karolinska Institutet in Stockholm, and colleagues examined the risk for metabolic and […]Continue Reading ...
A multidisciplinary team, led by Dr Marietta Stadler from the School of Life Course Sciences, has been awarded £1.25 million by the National Institute for Health Research (NIHR) to investigate an eating disorder where people with type 1 diabetes deliberately take too little insulin to try and control their weight. Dr Stadler, awarded one of […]Continue Reading ...
- New gene therapy cures babies with fatal ‘Bubble Boy’ disease
- No female mice? Scientists may still approve NIH grant
- What needs to be said about mental health in medicine
- Hickenlooper Expanded Medicaid, Created State-Run Marketplace To Insure Nearly All Coloradans
- Cancer cells grown in tumor-mimicking environment can help predict the effect of experimental drugs
- Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
- Adhesive gel bonds to eye surface, could repair injuries without surgery
- The future of genomics: A podcast featuring Stanford geneticists
- As Syphilis Invades Rural America, A Fraying Health Safety Net Is Failing To Stop It
- APOE gene impacts sleep depending on gender and severity of Alzheimer’s
- PCORI’s newly approved awards focus on cancer pain and opioid use disorders
- New tool provides a standard way to measure effects of caring for survivors of TBI
- Smartphone use risks eye examination misdiagnosis
- How drug-resistant bugs grow in CF patients’ lungs
- Gordana Vunjak-Novakovic Elected to American Academy of Arts & Sciences
- Podcast: KHN’s ‘What The Health?’ You Have Questions, We Have Answers
- Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients
- New estimation method assesses natural variations in sex ratio at birth
- UTA scientist receives $1.17 million grant for cancer research
- Coagulation factor VIIa prevents bleeds in hemophilia animal models